FINANCING AND ADDITIONAL SERVICESFinancing and Additional Services • October 12th, 2021 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations
Contract Type FiledOctober 12th, 2021 Company IndustryThis Agreement supersedes all prior or contemporaneous negotiations, commitments, agreements and writings with respect to the subject matter hereof, all such other negotiations, commitments, agreements and writings will have no further force or effect, and the parties to any such other negotiation, commitment, agreement or writing will have no further rights or obligations thereunder. This is a Confidential Agreement and may only be viewed by the intended recipients and their legal and accounting representatives. RespireRx Pharmaceuticals Inc., which includes its subsidiaries and affiliates (the “Company”) is strictly prohibited from reproducing or disseminating this Agreement without the prior written consent of Primary Capital LLC (“PC”). Notwithstanding the foregoing, upon execution, PC consents that this agreement will be summarized and included as an exhibit in an offering statement or any other required or advisable filing with the SEC.
FINANCING AND ADDITIONAL SERVICESFinancing and Additional Services • August 9th, 2021 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations
Contract Type FiledAugust 9th, 2021 Company IndustryThis Agreement supersedes all prior or contemporaneous negotiations, commitments, agreements and writings with respect to the subject matter hereof, all such other negotiations, commitments, agreements and writings will have no further force or effect, and the parties to any such other negotiation, commitment, agreement or writing will have no further rights or obligations thereunder. This is a Confidential Agreement and may only be viewed by the intended recipients and their legal and accounting representatives. RespireRx Pharmaceuticals Inc., which includes its subsidiaries and affiliates (the “Company”) is strictly prohibited from reproducing or disseminating this Agreement without the prior written consent of Primary Capital LLC (“PC”). Notwithstanding the foregoing, upon execution, PC consents that this agreement will be summarized and included as an exhibit in an offering statement or any other required or advisable filing with the SEC.